The Role of Immune Checkpoint Inhibitors in Metastatic Pancreatic Cancer: Current State and Outlook

Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest tumors, characterized by its aggressive tumor biology and poor prognosis. While immune checkpoint inhibitors (ICIs) play a major part in the treatment algorithm of various solid tumors, there is still no evidence of clinical benefit fro...

Descripción completa

Detalles Bibliográficos
Autores principales: Tran, Linh Chi, Özdemir, Berna C., Berger, Martin D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10609661/
https://www.ncbi.nlm.nih.gov/pubmed/37895882
http://dx.doi.org/10.3390/ph16101411

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10609661/
https://www.ncbi.nlm.nih.gov/pubmed/37895882
http://dx.doi.org/10.3390/ph16101411

Ejemplares similares